Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000117

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Williams Gregory C. CHIEF OPERATING OFFICER 2019-01-30 Grant or award · Stock Options +100,000 100,000 D: show line 1 in the form
Williams Gregory C. CHIEF OPERATING OFFICER 2019-01-30 Grant or award · Restricted Stock Units +30,000 30,000 D: show line 2 in the form
Loading xslF345X03/form4-01312019_050137.xml…